首页|我院2010-2012年颅内恶性肿瘤患者用药情况分析

我院2010-2012年颅内恶性肿瘤患者用药情况分析

扫码查看
目的:分析并评价我院2010-2012年颅内恶性肿瘤患者的用药情况。方法利用统计软件对我院神经外科2010-2012年的恶性肿瘤患者的用药种类、用药总量、销售价格等进行统计,并计算各种药物的DDC、DDDs以及B/A。结果颅内恶性肿瘤患者的用药种类广,几乎各类药均有使用,其中主要使用的药物包括抗感染药物(35.27%)、神经系统药物(16.48%)、心血管系统药物(11.83%)。结论颅内恶性肿瘤患者需要多种药物协同应用,其中抗感染药物占首位。我院对颅内恶性肿瘤患者的用药情况基本合理,在治疗中根据患者的个体差异,随时调整药物的种类和剂量,具体问题具体分析。
Analysis on Drugs use of intracranial malignant tumor patients in our hospital from 2010 to 2012
Objective To analyse and evaluate the usage of drugs for intracranial malignant tumor patients of our hospital from 2010 to 2012. Methods The kinds,dose,sales price of the drug in the malignant tumor patients from 2010 to 2012 in Department of neurosurgery in our hospital were statistically summarized by statistical software, and DDC, DDDs and B/A of various drugs were calculated. Results The drug species used in patients with malignant intracranial tumor were wide, almost all kinds of drugs were used, which mainly include the use of anti infective drugs(35.2%), nervous system drugs(16.48%), cardiovascular drugs(11.83%). Conclusion Intracranial malignant tumor patients need multiple drugs collaborative applications, in which anti-infection drugs account for the first. The use of drugs in our hospital of patients with intracranial malignant tumors is basically reasonable, according to the individual difference of the patient, the type and dose of drugs need to adjust at any time in the treatment, concrete problems need concrete analysis.

Malignant intracranial tumorAnalysis of drug useDDCDDDs

李越云

展开 >

239000 安徽省滁州市第一人民医院药剂科

颅内恶性肿瘤 用药分析 DDC DDDs

2013

中国医疗前沿
中国医院协会

中国医疗前沿

影响因子:0.186
ISSN:1673-5552
年,卷(期):2013.(21)
  • 1